U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C6H11N
Molecular Weight 97.1582
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of N-VINYLPYRROLIDINE

SMILES

C=CN1CCCC1

InChI

InChIKey=UDJZTGMLYITLIQ-UHFFFAOYSA-N
InChI=1S/C6H11N/c1-2-7-5-3-4-6-7/h2H,1,3-6H2

HIDE SMILES / InChI

Approval Year

PubMed

PubMed

TitleDatePubMed
Cytocompatibility studies of mouse pancreatic islets on gelatin--PVP semi IPN scaffolds in vitro: potential implication towards pancreatic tissue engineering.
2010-12-16
Bypassing multidrug resistance in cancer cells with biodegradable polymer capsules.
2010-12-14
Synthesis, characterization, and reaction studies of a PVP-capped platinum nanocatalyst immobilized on silica.
2010-11-02
Effect of chemical additives on biomass deposition onto beaded adsorbents.
2010-11
Evasion of the accelerated blood clearance phenomenon by coating of nanoparticles with various hydrophilic polymers.
2010-10-11
Small scale screening to determine the ability of different polymers to inhibit drug crystallization upon rapid solvent evaporation.
2010-08-02
Thermally cross-linked PNVP films as antifouling coatings for biomedical applications.
2010-08
Subcompartmentalized polymer hydrogel capsules with selectively degradable carriers and subunits.
2010-07-19
Polycationic polymers and drugs: investigations into interactions between acyclovir and polymers.
2010-07
Thermodynamic investigation of the systems poly(ethylene glycol) + sodium pentane-1-sulfonate + water and poly(vinyl pyrrolidone) + sodium pentane-1-sulfonate + water.
2010-06-01
Silver nanoparticles up-regulate Connexin43 expression and increase gap junctional intercellular communication in human lung adenocarcinoma cell line A549.
2010-06
Synthesis and characterization of glucocorticoid functionalized poly(N-vinyl pyrrolidone): a versatile prodrug for neural interface.
2010-05-10
Effect of polymer hygroscopicity on the phase behavior of amorphous solid dispersions in the presence of moisture.
2010-04-05
In situ time-resolved XAFS study on the formation mechanism of Cu nanoparticles using poly(N-vinyl-2-pyrrolidone) as a capping agent.
2010-03-16
Towards a green hydrate inhibitor: imaging antifreeze proteins on clathrates.
2010-02-11
Etching and dimerization: a simple and versatile route to dimers of silver nanospheres with a range of sizes.
2010
Sculptured drug-eluting stent for the on-site delivery of tacrolimus.
2009-11
Translational and rotational diffusion of a small globular protein under crowded conditions.
2009-10-08
Preparation, characterization and drug release behavior of polyion complex micelles.
2009-06-05
Improved physical stability of amorphous state through acid base interactions.
2009-06
Determination of the structural relaxation at the surface of amorphous solid dispersion using inverse gas chromatography.
2009-06
An investigation into the rheology of pharmaceutical inter-granular material bridges at high shear rates.
2009-05
Adsorption of actives in ophthalmological drugs for over-the-counter on soft contact lens surfaces.
2009
Triggered enzymatic degradation of DNA within selectively permeable polymer capsule microreactors.
2009
Solvent effects on the formation of nanoparticles and multilayered coatings based on hydrogen-bonded interpolymer complexes of poly(acrylic acid) with homo- and copolymers of N-vinyl pyrrolidone.
2008-12-02
Superdispersible PVP-coated Fe3O4 nanocrystals prepared by a "one-pot" reaction.
2008-11-20
Effect of polymer type on the dissolution profile of amorphous solid dispersions containing felodipine.
2008-10
Long-term success rate of perforated punctal plugs in the management of acquired punctal stenosis.
2008-09-23
Synthesis of ruthenium particles by photoreduction in polymer solutions.
2008-09-01
Synthesis of Pt/Ru bimetallic nanoparticles in high-temperature and high-pressure fluids.
2008-06-01
Poly(N-vinyl-2-pyrrolidone) (PVP)-capped dendritic gold nanoparticles by a one-step hydrothermal route and their high SERS effect.
2008-03-04
Stable luminescence from individual carbon nanotubes in acidic, basic, and biological environments.
2008-02-27
Molecular iodine preconcentration and determination in aqueous samples using poly(vinylpyrrolidone) containing membranes.
2008-02-15
Ice nucleation and supercooling behavior of polymer aqueous solutions.
2008-02
Modulation of a pulsatile release drug delivery system using different swellable/rupturable materials.
2007-11
Poly(vinylidene fluoride)-graft-poly(N-vinyl-2-pyrrolidone) copolymers prepared via a RAFT-mediated process and their use in antifouling and antibacterial membranes.
2007-09-11
In situ XAFS studies of Au particle formation by photoreduction in polymer solutions.
2007-06-05
New three-arm amphiphilic and biodegradable block copolymers composed of poly(epsilon-caprolactone) and poly(N-vinyl-2-pyrrolidone). Synthesis, characterization and self-assembly in aqueous solution.
2007-06-01
Investigation of the release mechanism of a sparingly water-soluble drug from solid dispersions in hydrophilic carriers based on physical state of drug, particle size distribution and drug-polymer interactions.
2007-06
Enhanced release of indomethacin from Pvp/stearic acid microcapsules prepared coupling Co-freeze-drying and ultrasound assisted spray-congealing process.
2007-03
Mechanisms of solute and fluid removal in hemodiafiltration.
2007
Influence of different polymers on the crystallization tendency of molecularly dispersed amorphous felodipine.
2006-12
The influence of PVP incorporation on moisture-induced surface crystallization of amorphous spray-dried lactose particles.
2006-09-14
Characteristics of bicalutamide solid dispersions and improvement of the dissolution.
2006-09
Examination of the effects of poly(N-vinylpyrrolidinone) hydrogels in direct and indirect contact with cells.
2006-05
Development of pulsatile systems for targeted drug delivery of celecoxib for prophylaxis of colorectal cancer.
2006-03-25
Controlled systemic delivery of indomethacin using membrane-moderated, cream formulation-based transdermal devices.
2006-03-25
Enhancement of the flux for polypropylene hollow fiber membrane in a submerged membrane-bioreactor by surface modification.
2006
Spontaneous formation of nanoparticle stripe patterns through dewetting.
2005-12
Optimization of protein therapies by polymer-conjugation as an effective DDS.
2005-01-31
Patents

Patents

Name Type Language
N-VINYLPYRROLIDINE
Systematic Name English
N-VINYLPYROLIDONE-
Preferred Name English
PYRROLIDINE, 1-ETHENYL-
Systematic Name English
PYRROLIDINE, 1-VINYL-
Systematic Name English
1-ETHENYLPYRROLIDINE
Systematic Name English
Code System Code Type Description
PUBCHEM
3014294
Created by admin on Mon Mar 31 18:56:35 GMT 2025 , Edited by admin on Mon Mar 31 18:56:35 GMT 2025
PRIMARY
FDA UNII
BGQ0JZ9FNA
Created by admin on Mon Mar 31 18:56:35 GMT 2025 , Edited by admin on Mon Mar 31 18:56:35 GMT 2025
PRIMARY
DAILYMED
BGQ0JZ9FNA
Created by admin on Mon Mar 31 18:56:35 GMT 2025 , Edited by admin on Mon Mar 31 18:56:35 GMT 2025
PRIMARY
EPA CompTox
DTXSID70196500
Created by admin on Mon Mar 31 18:56:35 GMT 2025 , Edited by admin on Mon Mar 31 18:56:35 GMT 2025
PRIMARY
EVMPD
SUB193776
Created by admin on Mon Mar 31 18:56:35 GMT 2025 , Edited by admin on Mon Mar 31 18:56:35 GMT 2025
PRIMARY
CAS
4540-16-3
Created by admin on Mon Mar 31 18:56:35 GMT 2025 , Edited by admin on Mon Mar 31 18:56:35 GMT 2025
PRIMARY
SMS_ID
100000178178
Created by admin on Mon Mar 31 18:56:35 GMT 2025 , Edited by admin on Mon Mar 31 18:56:35 GMT 2025
PRIMARY